S&P 500 slips, but losses kept in check as Nvidia climbs ahead of results
CHICAGO—Marcus Jonathan L, Senior Managing Director and General Counsel at CME Group Inc. (NASDAQ:CME), has recently sold a portion of his company shares. The transaction comes as CME Group, with a market capitalization of over $101 billion, trades near its 52-week high of $286.48, having delivered a strong 27% return over the past six months. According to a filing with the Securities and Exchange Commission, Marcus sold 390 shares of Common Stock Class A on May 20, 2025. The shares were sold at a price of $277.50 each, amounting to a total transaction value of $108,225.
Following this transaction, Marcus holds 6,708 shares in the company. The sale was executed under a pre-arranged trading plan, known as a Rule 10b5-1 plan, which Marcus adopted on February 18, 2025.
In other recent news, CME Group has been the focus of multiple analyst evaluations and corporate developments. UBS reaffirmed its Buy rating and maintained a $305 price target for CME Group, citing the company’s strong competitive position and potential growth through new product offerings. Argus Research also raised its price target to $308, maintaining a Buy rating due to anticipated growth in contract volumes amid economic and geopolitical conditions. Meanwhile, Barclays (LON:BARC) adjusted its price target slightly upwards to $283, maintaining an Equalweight rating, following an earnings report that met EPS expectations but fell short on revenue.
RBC Capital Markets kept its Sector Perform rating with a $269 target, highlighting CME Group’s ability to capitalize on market volatility and growth in the Market and Data Information segment. In corporate governance developments, CME Group announced the results of its 2025 Annual Meeting of Shareholders, where fourteen Equity Directors were elected, ensuring leadership continuity. The appointment of Ernst & Young LLP as the independent public accounting firm was ratified, and executive compensation practices were approved by shareholders. However, a quorum issue left some Class B Director positions as holdovers until the next election. These recent developments reflect CME Group’s strategic positioning and response to dynamic market conditions.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.